Inspire Medical Systems (INSP) Stock Forecast, Price & News

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last twelve months. There are currently 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" INSP shares.
View INSP analyst ratings or view top-rated stocks.

11 brokerages have issued 12 month price objectives for Inspire Medical Systems' stock. Their INSP share price forecasts range from $308.00 to $380.00. On average, they predict the company's stock price to reach $345.08 in the next twelve months. This suggests a possible upside of 79.0% from the stock's current price.
View analysts price targets for INSP or view top-rated stocks among Wall Street analysts.

Inspire Medical Systems' stock was trading at $251.88 on January 1st, 2023. Since then, INSP shares have decreased by 23.5% and is now trading at $192.75.
View the best growth stocks for 2023 here.

Inspire Medical Systems saw a increase in short interest in September. As of September 15th, there was short interest totaling 1,180,000 shares, an increase of 14.6% from the August 31st total of 1,030,000 shares. Based on an average daily volume of 512,100 shares, the short-interest ratio is presently 2.3 days.
View Inspire Medical Systems' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our INSP earnings forecast.

Inspire Medical Systems, Inc. (NYSE:INSP) posted its quarterly earnings results on Tuesday, August, 1st. The company reported ($0.41) EPS for the quarter, beating the consensus estimate of ($0.51) by $0.10. The firm had revenue of $151.09 million for the quarter, compared to the consensus estimate of $136.47 million. Inspire Medical Systems had a negative trailing twelve-month return on equity of 8.21% and a negative net margin of 7.81%. The firm's revenue was up 65.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.53) EPS.

ETFs with the largest weight of Inspire Medical Systems (NYSE:INSP) stock in their portfolio include Harbor Health Care ETF (MEDI), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Fidelity Digital Health ETF (FDHT), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), BNY Mellon Innovators ETF (BKIV), Principal Healthcare Innovators ETF (BTEC), Franklin Intelligent Machines ETF (IQM) and WisdomTree U.S. Growth & Momentum Fund (WGRO).

Inspire Medical Systems updated its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $600.00 million-$610.00 million, compared to the consensus revenue estimate of $589.63 million.

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

(INSP) raised $75 million in an IPO on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Inspire Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "INSP."

Inspire Medical Systems' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.19%), Franklin Resources Inc. (3.56%), William Blair Investment Management LLC (2.85%), Champlain Investment Partners LLC (1.93%), State Street Corp (1.75%) and Wasatch Advisors LP (1.69%). Insiders that own company stock include Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert.
View institutional ownership trends.

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of INSP stock can currently be purchased for approximately $192.75.

Inspire Medical Systems (NYSE:INSP) has a market capitalization of $5.66 billion and generates $407.86 million in revenue each year. The company earns $-44,880,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.

The company employs 755 workers across the globe.

Inspire Medical Systems' mailing address is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. The official website for the company is www.inspiresleep.com. The company can be reached via phone at (844) 672-4357 or via email at inspire@lifesciadvisors.com.